Ignite Creation Date:
2024-05-06 @ 8:23 PM
Last Modification Date:
2024-10-26 @ 3:26 PM
Study NCT ID:
NCT06362746
Status:
RECRUITING
Last Update Posted:
2024-06-21
First Post:
2024-04-02
Brief Title:
Non-immunogenic Recombinant Staphylokinase vs Placebo in Patients With Intermediate High-risk Pulmonary Embolism
Sponsor:
Supergene LLC
Organization:
Supergene LLC
Organization Data
Organization:
Supergene LLC
Class:
INDUSTRY
Study ID:
FORPE-2
Study Type:
None
Study Domain:
None
Study Link:
None
Lead Sponsor:
Supergene LLC
Lead Sponsor Class:
INDUSTRY
Responsible Party:
None
Responsible Party Title:
None
Responsible Party Type:
SPONSOR
Responsible Party Affiliation:
None
Old Name:
None
Old Organization:
None